Pacific Biosciences:Pacific Biosciences of California
Pacific Biosciences of California
PacificBiosciences(PACB)hasbeenoneofthestocksmostwatchedbyZacks.comuserslately.So,itisworthexploringwhatliesaheadforthestock.。其他文章還包含有:「AboutUs」、「INVESTORRELATIONS」、「PACB-PacificBiosciencesofCalifornia,Inc.」、「PacBio」、「PacBio台灣代理伯森生技」、「PacificBiosciences」、「PacificBiosciencesofCalifornia」、「PacificBiosciencestolayoff195employeesaspartofcost...」、「Sequenci...
查看更多 離開網站About Us
https://www.pacb.com
We create the world's most advanced sequencing systems to provide you the most complete and accurate view of genomes, transcriptomes, and epigenomes. Our ...
INVESTOR RELATIONS
http://investor.pacificbioscie
Pacific Biosciences of California, Inc. First Quarter 2024 Earnings Conference Call May 9, 2024 at 5:00 PM EDT. Barclays 26th Annual Global Healthcare ...
PACB-Pacific Biosciences of California, Inc.
https://www.moneydj.com
Pacific Biosciences of California, Inc. · 1305 O'brien Drive,Menlo Park,California 94025,United States Of America · 428,723,008 (2024/04/29) ...
PacBio
https://www.pacb.com
PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing ...
PacBio 台灣代理伯森生技
https://www.blossombio.com
Sequence with Confidence. Pacific Biosciences (PacBio) - PacBio 台灣代理伯森生技 PacBio 於2004 年在美國加州成立,其獨家開發的「單一分子即時定序(Single ...
Pacific Biosciences
https://en.wikipedia.org
Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene ...
Pacific Biosciences of California
https://hk.finance.yahoo.com
截止2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為USD。
Pacific Biosciences to lay off 195 employees as part of cost ...
https://www.medtechdive.com
Pacific Biosciences, which sells gene sequencing equipment, announced the layoffs on Thursday along with its first-quarter results, reporting a ...
Sequencing systems
https://www.pacb.com
PacBio is consistently working to further advance genomic sequencing systems to create a more diversified portfolio of platforms.
說明
https://en.wikipedia.org